Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
6,42 USD | +14,44 % | +18,89 % | -27,54 % |
13/05 | PRIME MEDICINE, INC. : JPMorgan Chase optimiste sur le dossier | ZM |
10/05 | Prime Medicine, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 | CI |
Métier
Nombre d'employés: 234
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 70 | 01/07/20 | |
Allan Reine
DFI | Director of Finance/CFO | 49 | 17/01 |
Chief Operating Officer | 52 | 01/09/22 | |
Jeremy Duffield
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/01/21 |
Ann Lee
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/10/21 |
Mohammed Asmal
CTO | Chief Tech/Sci/R&D Officer | - | - |
Fubao Wang
LAW | General Counsel | - | - |
Karen Brown
LAW | General Counsel | - | - |
Niamh Alix
HRO | Human Resources Officer | - | 01/06/22 |
Carman Alenson
AUD | Comptroller/Controller/Auditor | 58 | 01/08/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 64 | 01/12/21 | |
Robert Nelsen
BRD | Director/Board Member | 60 | 01/09/20 |
Michael Kelly
BRD | Director/Board Member | 67 | 01/11/21 |
David Schenkein
BRD | Director/Board Member | 66 | 13/09/19 |
Chief Executive Officer | 70 | 01/07/20 | |
Director/Board Member | 46 | 10/05/23 | |
Thomas Cahill
BRD | Director/Board Member | 37 | 01/11/21 |
Wendy Chung
BRD | Director/Board Member | 55 | 01/11/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 120 030 813 | 88 247 113 ( 73,52 %) | 0 | 73,52 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-27,54 % | 742 M | |
+5,66 % | 111 Md | |
+11,23 % | 105 Md | |
-2,50 % | 21,93 Md | |
-12,15 % | 22,34 Md | |
-5,52 % | 18,59 Md | |
-36,52 % | 18,12 Md | |
-10,09 % | 16,96 Md | |
+3,33 % | 13,7 Md | |
+36,58 % | 12,45 Md |
- Bourse
- Actions
- Action PRME
- Société Prime Medicine, Inc.